PCRX Pacira BioSciences, Inc.
Nasdaq · SEC CIK 1396814 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.53M 13 sales by 5 insiders
- Filings on record
- 191 since 2021-07-06, latest 2026-08-18 17:21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Cross Shawn | CFO | — | $1.52M |
| WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| RIKER LAUREN | SVP, Fin | — | $261.3K |
| SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| Froimson Mark | Dir | — | $10.9K |
| BIGAL MARCELO | Dir | — | — |
| Young Alethia | Dir | — | — |
| Teehan Brendan | Chief Commercial Off | — | — |
| Lee Frank D. | CEO, Dir | — | — |
| CHRISTIE CHRISTOPHER | Dir | — | — |
Transactions 236
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-18 17:21 | 2026-08-17 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $23.23 | -3,040 | 216.4K | -1% | -$70.6K |
| D | 2026-06-12 21:07 | 2026-06-10 | PCRX | Hirawat Samit | Dir | A - Grant | $0.00 | +6,405 | 6,405 | New | $0 |
| T | 2026-06-12 21:07 | 2026-06-11 | PCRX | RIKER LAUREN | SVP, Fin | S - Sale | $23.50 | -6,115 | 62.3K | -9% | -$143.7K |
| D | 2026-06-12 21:07 | 2026-06-10 | PCRX | CHRISTIE CHRISTOPHER | Dir | A - Grant | $0.00 | +6,405 | 23.1K | +38% | $0 |
| D | 2026-06-12 21:07 | 2026-06-10 | PCRX | Young Alethia | Dir | A - Grant | $0.00 | +6,405 | 17.8K | +56% | $0 |
| D | 2026-06-12 21:07 | 2026-06-10 | PCRX | YANG MICHAEL J. | Dir | A - Grant | $0.00 | +6,405 | 19.8K | +48% | $0 |
| D | 2026-06-12 21:07 | 2026-06-10 | PCRX | BIGAL MARCELO | Dir | A - Grant | $0.00 | +6,405 | 17.8K | +56% | $0 |
| D | 2026-06-12 21:06 | 2026-06-10 | PCRX | Froimson Mark | Dir | A - Grant | $0.00 | +6,405 | 26.5K | +32% | $0 |
| D | 2026-06-12 21:06 | 2026-06-10 | PCRX | Brege Laura | Dir | A - Grant | $0.00 | +6,405 | 30.1K | +27% | $0 |
| 2026-06-05 17:57 | 2026-06-03 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $22.32 | -3,187 | 68.4K | -4% | -$71.1K | |
| 2026-06-05 17:57 | 2026-06-03 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $22.32 | -4,728 | 218.9K | -2% | -$105.5K | |
| T | 2026-06-05 17:57 | 2026-06-03 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | F - Tax | $22.32 | -8,528 | 177.3K | -5% | -$190.3K |
| T | 2026-06-05 17:57 | 2026-06-04 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | S - Sale | $22.27 | -10.3K | 167.1K | -6% | -$228.5K |
| DT | 2026-04-24 20:41 | 2026-04-23 | PCRX | Cross Shawn | CFO | M - OptEx | $16.45 | +12.9K | 118.3K | +12% | +$212.9K |
| DT | 2026-04-24 20:41 | 2026-04-23 | PCRX | Cross Shawn | CFO | S - Sale+OE | $25.16 | -12.9K | 105.3K | -11% | -$325.6K |
| DMT | 2026-04-22 20:03 | 2026-04-20+ | PCRX | Cross Shawn | CFO | M - OptEx | $16.45 | +12.1K | 106.8K | +13% | +$198.4K |
| DMT | 2026-04-22 20:03 | 2026-04-20+ | PCRX | Cross Shawn | CFO | S - Sale+OE | $25.09 | -12.1K | 105.3K | -10% | -$302.6K |
| A | 2026-03-19 | 2025-06-11 | PCRX | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +6,163 | 31.1K | +25% | $0 |
| 2026-03-19 | 2026-03-17 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $22.82 | -3,261 | 223.6K | -1% | -$74.4K | |
| 2026-03-19 | 2026-03-17 | PCRX | Froimson Mark | Dir | S - Sale | $21.81 | -500 | 20.1K | -2% | -$10.9K | |
| 2026-02-13 | 2026-02-11 | PCRX | RIKER LAUREN | SVP, Fin | A - Grant | $0.00 | +19.3K | 71.6K | +37% | $0 | |
| 2026-02-13 | 2026-02-11 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | A - Grant | $0.00 | +54.5K | 185.8K | +42% | $0 | |
| 2026-02-13 | 2026-02-11 | PCRX | Lee Frank D. | CEO, Dir | A - Grant | $0.00 | +261.8K | 660.8K | +66% | $0 | |
| 2026-02-13 | 2026-02-11 | PCRX | Teehan Brendan | Chief Commercial Off | A - Grant | $0.00 | +51.7K | 100.9K | +105% | $0 | |
| 2026-02-13 | 2026-02-11 | PCRX | SLONIN JONATHAN | Chief Medical Off | A - Grant | $0.00 | +54.5K | 226.9K | +32% | $0 | |
| 2026-02-13 | 2026-02-11 | PCRX | Cross Shawn | CFO | A - Grant | $0.00 | +49.1K | 105.3K | +87% | $0 | |
| 2026-02-03 | 2026-01-30 | PCRX | Teehan Brendan | Chief Commercial Off | F - Tax | $20.54 | -5,182 | 49.2K | -10% | -$106.4K | |
| 2026-02-03 | 2026-01-30 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $20.54 | -6,168 | 172.4K | -3% | -$126.7K | |
| 2026-02-03 | 2026-01-30 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $20.54 | -2,751 | 56.3K | -5% | -$56.5K | |
| 2026-02-03 | 2026-02-02 | PCRX | RIKER LAUREN | SVP, Fin | S - Sale | $20.81 | -4,000 | 52.3K | -7% | -$83.2K | |
| 2026-02-03 | 2026-01-30 | PCRX | Lee Frank D. | CEO, Dir | F - Tax | $20.54 | -41.5K | 399.0K | -9% | -$852.2K | |
| 2026-02-03 | 2026-01-30 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | F - Tax | $20.54 | -17.1K | 144.4K | -11% | -$351.9K | |
| 2026-02-03 | 2026-02-02 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | S - Sale | $20.53 | -13.1K | 131.3K | -9% | -$269.7K | |
| 2026-01-06 | 2025-12-31 | PCRX | Teehan Brendan | Chief Commercial Off | A - Grant | $10.76 | +402.27 | 54.4K | +0.7% | +$4,328 | |
| 2026-01-06 | 2026-01-05 | PCRX | RIKER LAUREN | SVP, Fin | S - Sale | $24.24 | -1,416 | 59.1K | -2% | -$34.3K | |
| 2026-01-06 | 2026-01-02 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $24.46 | -159 | 60.5K | -0.3% | -$3,889 | |
| 2026-01-06 | 2026-01-02 | PCRX | Lee Frank D. | CEO, Dir | F - Tax | $24.46 | -9,272 | 440.5K | -2% | -$226.8K | |
| 2026-01-06 | 2026-01-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $24.46 | -381 | 178.5K | -0.2% | -$9,319 | |
| DM | 2025-12-11 | 2025-12-09+ | PCRX | Cross Shawn | CFO | M - OptEx | $16.45 | +25.0K | 72.1K | +53% | +$411.2K |
| DM | 2025-12-11 | 2025-12-09+ | PCRX | Cross Shawn | CFO | S - Sale+OE | $25.07 | -25.0K | 56.2K | -31% | -$626.8K |
| 2025-11-19 | 2025-11-17 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $24.09 | -3,960 | 178.4K | -2% | -$95.4K | |
| 2025-11-13 | 2025-11-10 | PCRX | Cross Shawn | CFO | S - Sale | $22.09 | -12.1K | 56.2K | -18% | -$266.4K | |
| 2025-11-03 | 2025-10-31 | PCRX | Cross Shawn | CFO | F - Tax | $21.38 | -6,690 | 68.3K | -9% | -$143.0K | |
| 2025-09-08 | 2025-09-04 | PCRX | Ceesay Abraham | Dir | S - Sale | $27.19 | -2,354 | 9,039 | -21% | -$64.0K | |
| 2025-08-11 | 2025-08-07 | PCRX | BIGAL MARCELO | Dir | S - Sale | $23.67 | -4,912 | 11.4K | -30% | -$116.3K | |
| 2025-08-04 | 2025-08-01 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $22.07 | -315 | 182.3K | -0.2% | -$6,952 | |
| D | 2025-06-13 | 2025-06-11 | PCRX | Young Alethia | Dir | A - Grant | $0.00 | +6,163 | 11.4K | +118% | $0 |
| D | 2025-06-13 | 2025-06-11 | PCRX | Brege Laura | Dir | A - Grant | $0.00 | +6,163 | 23.7K | +35% | $0 |
| D | 2025-06-13 | 2025-06-11 | PCRX | YANG MICHAEL J. | Dir | A - Grant | $0.00 | +6,163 | 13.4K | +85% | $0 |
| D | 2025-06-13 | 2025-06-11 | PCRX | CHRISTIE CHRISTOPHER | Dir | A - Grant | $0.00 | +6,163 | 16.7K | +59% | $0 |
| D | 2025-06-13 | 2025-06-11 | PCRX | Ceesay Abraham | Dir | A - Grant | $0.00 | +6,163 | 11.4K | +118% | $0 |
| D | 2025-06-13 | 2025-06-11 | PCRX | Froimson Mark | Dir | A - Grant | $0.00 | +6,163 | 20.6K | +43% | $0 |
| D | 2025-06-13 | 2025-06-11 | PCRX | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +9,999 | 34.9K | +40% | $0 |
| D | 2025-06-13 | 2025-06-11 | PCRX | BIGAL MARCELO | Dir | A - Grant | $0.00 | +6,163 | 16.3K | +61% | $0 |
| 2025-06-05 | 2025-06-03 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $26.40 | -5,084 | 182.0K | -3% | -$134.2K | |
| 2025-06-05 | 2025-06-03 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | F - Tax | $26.40 | -6,162 | 175.9K | -3% | -$162.7K | |
| 2025-06-05 | 2025-06-04 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | S - Sale | $26.24 | -14.4K | 161.6K | -8% | -$377.2K | |
| 2025-06-05 | 2025-06-03 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $26.40 | -3,374 | 65.1K | -5% | -$89.1K | |
| 2025-06-05 | 2025-06-04 | PCRX | RIKER LAUREN | SVP, Fin | S - Sale | $26.21 | -5,578 | 59.6K | -9% | -$146.2K | |
| 2025-02-04 | 2025-02-01 | PCRX | SLONIN JONATHAN | Chief Medical Off | A - Grant | $0.00 | +93.6K | 187.0K | +100% | $0 | |
| 2025-02-04 | 2025-02-01 | PCRX | RIKER LAUREN | SVP, Fin | A - Grant | $0.00 | +30.6K | 68.5K | +81% | $0 | |
| D | 2025-02-04 | 2025-02-01 | PCRX | Teehan Brendan | Chief Commercial Off | A - Grant | $0.00 | +54.0K | 54.0K | New | $0 |
| 2025-02-04 | 2025-02-01 | PCRX | Lee Frank D. | CEO, Dir | A - Grant | $0.00 | +350.0K | 448.4K | +356% | $0 | |
| 2025-02-04 | 2025-02-01 | PCRX | WILLIAMS KRISTEN | Chief Administrative Off | A - Grant | $0.00 | +79.2K | 182.1K | +77% | $0 | |
| 2025-01-06 | 2025-01-02 | PCRX | Lee Frank D. | CEO, Dir | F - Tax | $18.33 | -9,375 | 98.4K | -9% | -$171.8K | |
| 2025-01-06 | 2024-12-31 | PCRX | GAUGLER DARYL | COO | A - Grant | $16.01 | +243.54 | 115.4K | +0.2% | +$3,899 | |
| 2025-01-06 | 2025-01-02 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $18.33 | -159 | 37.9K | -0.4% | -$2,914 | |
| 2025-01-06 | 2025-01-06 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $18.40 | -879 | 93.4K | -0.9% | -$16.2K | |
| 2025-01-06 | 2025-01-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $18.33 | -371 | 94.3K | -0.4% | -$6,800 | |
| 2024-12-16 | 2024-12-13 | PCRX | GAUGLER DARYL | COO | S - Sale | $19.76 | -500 | 115.2K | -0.4% | -$9,880 | |
| D | 2024-11-05 | 2024-11-01 | PCRX | Cross Shawn | CFO | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| 2024-09-13 | 2024-09-13 | PCRX | GAUGLER DARYL | COO | S - Sale | $12.86 | -500 | 115.7K | -0.4% | -$6,430 | |
| 2024-08-19 | 2024-08-16 | PCRX | BIGAL MARCELO | Dir | P - Purchase | $13.25 | +1,512 | 10.1K | +18% | +$20.0K | |
| 2024-08-19 | 2024-08-16 | PCRX | Brege Laura | Dir | P - Purchase | $12.81 | +1,000 | 17.6K | +6% | +$12.8K | |
| 2024-08-14 | 2024-08-14 | PCRX | YANG MICHAEL J. | Dir | P - Purchase | $12.90 | +2,000 | 7,230 | +38% | +$25.8K | |
| 2024-08-13 | 2024-08-12 | PCRX | Lee Frank D. | CEO, Dir | P - Purchase | $12.10 | +8,264 | 107.8K | +8% | +$100.0K | |
| A | 2024-08-13 | 2024-08-12 | PCRX | BIGAL MARCELO | Dir | P - Purchase | $12.01 | +3,400 | 8,630 | +65% | +$40.8K |
| 2024-08-12 | 2024-08-12 | PCRX | BIGAL MARCELO | Dir | P - Purchase | $12.01 | +3,400 | 8,630 | +65% | +$40.8K | |
| 2024-08-12 | 2024-08-12 | PCRX | Froimson Mark | Dir | P - Purchase | $11.58 | +1,400 | 14.5K | +11% | +$16.2K | |
| 2024-08-02 | 2024-08-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $20.05 | -945 | 94.3K | -1.0% | -$18.9K | |
| 2024-08-02 | 2024-08-01 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $20.75 | -305 | 95.3K | -0.3% | -$6,329 | |
| 2024-07-03 | 2024-06-28 | PCRX | GAUGLER DARYL | COO | A - Grant | $24.32 | +160.37 | 116.2K | +0.1% | +$3,900 | |
| 2024-07-03 | 2024-07-01 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $28.46 | -914 | 98.4K | -0.9% | -$26.0K | |
| 2024-07-03 | 2024-07-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $28.25 | -2,836 | 95.6K | -3% | -$80.1K | |
| 2024-07-03 | 2024-06-28 | PCRX | SLONIN JONATHAN | Chief Medical Off | A - Grant | $24.32 | +437.27 | 99.3K | +0.4% | +$10.6K | |
| D | 2024-06-13 | 2024-06-12 | PCRX | BIGAL MARCELO | Dir | A - Grant | $0.00 | +5,230 | 5,230 | New | $0 |
| D | 2024-06-13 | 2024-06-12 | PCRX | HASTINGS PAUL J | Dir | A - Grant | $0.00 | +5,230 | 13.6K | +62% | $0 |
| D | 2024-06-13 | 2024-06-13 | PCRX | HASTINGS PAUL J | Dir | S - Sale | $28.38 | -880 | 12.7K | -6% | -$25.0K |
| D | 2024-06-13 | 2024-06-12 | PCRX | CHRISTIE CHRISTOPHER | Dir | A - Grant | $0.00 | +5,230 | 10.5K | +99% | $0 |
| 2024-06-13 | 2024-06-13 | PCRX | GAUGLER DARYL | COO | S - Sale | $28.38 | -1,000 | 116.0K | -0.9% | -$28.4K | |
| 2024-06-13 | 2024-06-12 | PCRX | GAUGLER DARYL | COO | A - Grant | $0.00 | +54.3K | 117.0K | +87% | $0 | |
| D | 2024-06-13 | 2024-06-12 | PCRX | Kronenfeld Mark A. | Dir | A - Grant | $0.00 | +5,230 | 24.9K | +27% | $0 |
| D | 2024-06-13 | 2024-06-12 | PCRX | Brege Laura | Dir | A - Grant | $0.00 | +5,230 | 16.6K | +46% | $0 |
| D | 2024-06-13 | 2024-06-12 | PCRX | Froimson Mark | Dir | A - Grant | $0.00 | +5,230 | 13.1K | +67% | $0 |
| D | 2024-06-13 | 2024-06-12 | PCRX | Young Alethia | Dir | A - Grant | $0.00 | +5,230 | 5,230 | New | $0 |
| 2024-06-13 | 2024-06-11 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $28.57 | -5,012 | 44.6K | -10% | -$143.2K | |
| 2024-06-13 | 2024-06-12 | PCRX | SLONIN JONATHAN | Chief Medical Off | A - Grant | $0.00 | +54.3K | 98.9K | +122% | $0 | |
| 2024-06-13 | 2024-06-12 | PCRX | Reinhart Charles A. III | CFO | A - Grant | $0.00 | +12.2K | 51.9K | +31% | $0 | |
| D | 2024-06-13 | 2024-06-12 | PCRX | Ceesay Abraham | Dir | A - Grant | $0.00 | +5,230 | 5,230 | New | $0 |
| 2024-06-13 | 2024-06-12 | PCRX | RIKER LAUREN | SVP, Fin | A - Grant | $0.00 | +21.4K | 42.0K | +103% | $0 |
Purchase Sale Sale after option exercise All abbreviations